Nautilus Biotechnology
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $234 | $190 | $0 | $0 |
Gross Profit | 210 | 1,317 | -1,476 | -1,588 |
EBITDA | -14,332 | -14,479 | -13,221 | -12,193 |
EBIT | -15,636 | -15,763 | -14,697 | -13,781 |
Net Income | -15,636 | -14,469 | -14,697 | -13,781 |
Net Change In Cash | 234 | 190 | 0 | 0 |
Free Cash Flow | -14,726 | -14,180 | -13,610 | -12,619 |
Cash | 10,467 | 13,166 | 14,626 | 12,388 |
Basic Shares | 127,238 | 126,886 | 126,634 | 126,256 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6,465 | -6,353 | -5,705 | -3,416 |
EBITDA | -52,536 | -64,427 | -57,970 | -60,080 |
EBIT | -59,001 | -70,780 | -63,675 | -63,496 |
Net Income | -59,001 | -70,780 | -63,675 | -57,924 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -70,984 | |||
Free Cash Flow | -51,973 | -61,267 | -54,153 | -48,130 |
Cash | 12,388 | 27,646 | 19,397 | 114,523 |
Basic Shares | 126,256 | 125,427 | 124,919 | 124,589 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.12 |
2026-06-30 | -$0.11 |
2026-03-31 | -$0.12 |
2025-12-31 | -$0.11 |